Skip to content
Bored Studies
Recruiting

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Viome · NCT05465616

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
150
US sites recruiting
1
Study start
August 22, 2022
Record last updated
January 24, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.

Being studied: Viome's Precision Nutrition Program (VPNP)

Conditions: Diabetes; Pre Diabetes

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Signed and dated informed consent form and medical release prior to any trial-specific procedures are performed
  • Females and males aged 18 years or older
  • Able to speak and read English
  • HbA1c between 5.7-8.9% (inclusive), tested within the past 30 days
  • Willing and able to visit a Quest Diagnostic Patient Service Center (PSC)
  • Willing and able to follow the trial instructions and Viome's Precision Nutrition Program
  • Willing and able to use a smartphone and Viome app.

Exclusion Criteria

  • Antibiotic use within one month of the GI test
  • Gestation within previous 6 month
  • Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.)
  • Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.)
  • On a specific diet, such as ketogenic, for the purpose of reducing HbA1c and/or weight within the previous month
  • Taking diet pills
  • Allergy to an ingredient in the MH capsule or stick pack
  • Currently on an investigational product
  • Significant surgery or medical procedure planned
  • Diet or lifestyle change during the trial period, besides those appropriate for trial arm Has followed Viome nutritional recommendations (foods and/or supplements)

Recruiting US locations

  • Viome Life Sciences

    Bothell, WA 98011

    Site contact: Momchilo Vuyisich, PhD · 425-300-6933 · studies@viome.com

Study contacts (from the official record)

  • Mory Mehrtash · (425) 300-6933 · studies@viome.com
  • Momchilo Vuyisich · (425) 300-6933 · studies@viome.com
All diabetes studies in Washington →
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c (NCT05465616) | Bored Studies